Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
As monotherapy, cagrilintide produced 11.8% weight loss in the Phase 3 REDEFINE 1 trial at 68 weeks with the 2.4 mg dose
Any concerns should be discussed with your healthcare provider before beginning treatment
Our team has studied the literature, consulted with prescribers, spoken with users, and tried peptides for ourselves
Ethics statement The animal study was reviewed and approved by the Laboratory Animal Welfare and Ethics Committee of Fourth Military Medical University
US$ 25.37
US$ 21.05
US$ 23.78
US$ 23.13
US$ 22.84
US$ 28.42
US$ 25.11
US$ 26.44
US$ 25.02
US$ 25.13
